MicroPort NeuroScientific Corporation announced that the company’s Apollo Dream sirolimus target-eluting stent system has b ...
MicroPort announced that it received FDA breakthrough device designation for its Apollo Dream sirolimus target-eluting stent ...
Launch Will Test GPS-denied Navigation Module During Atmospheric Reentry WASHINGTON, DC, UNITED STATES, March 31, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results